Hot Picks: Biotech stocks to watch as new drugs near market [BNN Bloomberg (Canada)]
Insmed, Inc. (INSM)
Last insmed, inc. earnings: 4/30 07:30 am
Check Earnings Report
US:NASDAQ Investor Relations:
investor.insmed.com
Company Research
Source: BNN Bloomberg
BNN Bloomberg spoke with Ritu Baral, managing director of health care and biotechnology at TD Cowen, about three biotech stocks she sees as well positioned based on recent approvals, late-stage trials and upcoming data catalysts. Key Takeaways Biotech opportunities are increasingly centred on drugs targeting severe and underserved conditions with limited existing treatment options. Recently approved therapies entering early launch phases can become major valuation drivers as adoption accelerates. Neurological disorders such as essential tremor represent large markets with significant unmet medical need and quality-of-life impact. Late-stage clinical programs approaching regulatory filings can create rapid growth inflection points for biotech stocks. Small-cap biotech names with upcoming binary trial data carry higher risk but can offer substantial upside if results are positive. Read the full transcript below: ROGER: Time now for Hot Picks, and our next guest covers t
Show less
Read more
Impact Snapshot
Event Time:
INSM
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
INSM alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
INSM alerts
High impacting Insmed, Inc. news events
Weekly update
A roundup of the hottest topics
INSM
News
- Insmed (NASDAQ:INSM) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $225.00 to $258.00. They now have a "buy" rating on the stock.MarketBeat
- Insmed (INSM): Assessing Valuation After a Strong Year of Share Price Gains [Yahoo! Finance]Yahoo! Finance
- Is It Too Late to Consider Insmed After a 179% Surge and DCF Upside? [Yahoo! Finance]Yahoo! Finance
- Insmed (NASDAQ:INSM) had its price target raised by analysts at TD Cowen from $231.00 to $269.00. They now have a "buy" rating on the stock.MarketBeat
- Billionaire Stanley Druckenmiller is Betting $1.2 Billion in These 3 Stocks [Yahoo! Finance]Yahoo! Finance
INSM
Earnings
- 10/30/25 - Miss
INSM
Sec Filings
- 12/9/25 - Form 4
- 12/5/25 - Form 144
- 12/5/25 - Form 4
- INSM's page on the SEC website